Tuesday brought a fresh batch of analyst rating changes as top Wall Street firms revised their outlooks on several notable companies. Here's what you need to know about the five stocks catching upgrades.
RBC Capital analyst Daniel Perlin moved Jack Henry & Associates Inc (JKHY) from Sector Perform to Outperform, pushing the price target from $185 to $210. The financial technology company's shares closed at $187.65 on Monday, suggesting the analyst sees additional upside from current levels.
Keybanc analyst Jason Celino upgraded Trimble Inc (TRMB) from Sector Weight to Overweight and set a $99 price target. That represents meaningful optimism considering Trimble shares closed at $80.17 on Monday—the new target implies roughly 23% upside potential.
In the medical device space, Baird analyst Jeff Johnson upgraded Tandem Diabetes Care Inc (TNDM) from Neutral to Outperform and boosted the price target from $18 to $30. With shares closing at $22.11 on Monday, Johnson's new target suggests he sees room for further gains following what appears to be a recent recovery.
ServiceNow Inc (NOW) got a more modest vote of confidence from Guggenheim analyst John Difucci, who upgraded the enterprise software company from Sell to Neutral. ServiceNow shares closed at $765.20 on Monday. While Neutral isn't exactly a ringing endorsement, it does signal the analyst no longer expects the stock to underperform.
Perhaps the most interesting move came from Goldman Sachs analyst Joe Ritchie, who upgraded Rockwell Automation Inc (ROK) from Sell to Neutral. But here's the kicker: he also raised the price target from $329 all the way to $448. That's a substantial 36% increase in the target price. With Rockwell shares closing at $401.65 on Monday, the new target still implies some upside, and the rating change suggests Ritchie's bearish thesis on the industrial automation giant has run its course.
These upgrades reflect shifting analyst perspectives as companies navigate current market conditions and business fundamentals evolve. Whether these revised ratings prove prescient remains to be seen, but they certainly signal changing conviction among some of Wall Street's research teams.
